Sera Prognostics, developer of a prenatal test to predict birth risk, has raised $40m in a round led by its new distribution partner, LabCorp.

Life sciences research company Laboratory Corporation of America (LabCorp) is leading a $40m series C round for prenatal diagnostics technology developer Sera Prognostics as part of a strategic collaboration agreement.

Founded in 2008, Sera is developing a blood testing system called PreTRM that will be able to predict birth risks from 19 weeks of pregnancy onwards by analysing proteins in the blood. The agreement, announced on Tuesday, means LabCorp will be the exclusive distributor of PreTRM in the US.

The…